Core Viewpoint - The research indicates that Paroxetine, a commonly used antidepressant, shows significant efficacy against malignant melanoma, particularly in cases with BRAF V600E mutations that are resistant to targeted therapies [3][5]. Group 1: Research Findings - A study published in Cell Reports Medicine reveals that Paroxetine induces pyroptosis in melanoma cells, a unique mechanism of cell death distinct from traditional apoptosis [3][7]. - The mechanism involves blocking serotonin reuptake, leading to reduced intracellular serotonin levels, which affects DNA repair gene expression and ultimately results in DNA damage accumulation and endoplasmic reticulum stress [7][9]. - Paroxetine is effective against BRAFi/MEKi resistant melanoma due to lower expression of TPH1, making these cells more sensitive to treatment [11]. Group 2: Clinical Implications - The findings suggest multiple clinical benefits: Paroxetine is an already approved drug with known safety, allowing for quicker clinical application [14]. - It serves dual purposes as both an antidepressant and an anti-cancer agent, making it particularly suitable for advanced cancer patients [14]. - The drug offers new options for patients with resistance to targeted therapies and enhances the effectiveness of immune therapies by transforming "cold tumors" into "hot tumors" [11][14].

Core Viewpoint - The article discusses the condition of obsessive-compulsive disorder (OCD) through the case of an 18-year-old college student, highlighting its symptoms, treatment options, and the importance of family support in the recovery process [1][2][8]. Summary by Sections Definition and Symptoms - OCD is characterized by obsessive thoughts and compulsive behaviors that significantly impact daily life, work, and relationships [2]. - Obsessive thoughts are intrusive ideas that cause excessive anxiety, while compulsive behaviors are repetitive actions aimed at reducing this anxiety [2]. Treatment Options - First-line treatments for OCD include medication and psychological therapy. Common medications include fluvoxamine, sertraline, paroxetine, and fluoxetine, while cognitive behavioral therapy (CBT) is the most recommended psychological treatment [3]. - Medication typically takes 4 to 6 weeks to show effects, with some initial side effects like dry mouth and drowsiness, which usually subside [3]. - CBT, particularly the exposure and response prevention (ERP) technique, is effective in helping patients manage their anxiety and regain control over their symptoms [5]. Integrated Treatment Approach - The hospital employs an individualized and integrated treatment model that combines medication, psychological therapy, physical therapy, and traditional Chinese medicine to maximize treatment effectiveness [7]. - Patients are encouraged to participate in group therapy and individual sessions to learn coping strategies and become their own therapists [7]. Family Involvement - Family support is crucial in the treatment of OCD, as family members can inadvertently enable the disorder by accommodating the patient's compulsive behaviors [8]. - Education for family members is provided to help them respond appropriately to the patient's symptoms and reduce the risk of relapse after discharge [8]. Additional Treatment Methods - Other treatment methods include physical therapies such as transcranial magnetic stimulation, relaxation techniques, and acupuncture, which complement medication and psychological therapy [9][10]. Recovery Potential - With dedicated effort from both patients and healthcare providers, most individuals with OCD can return to normal life. Long-term commitment to therapy, such as mindfulness practices, can lead to successful outcomes [12].